D-1030-2020 Class II Terminated
FDA drug recall D-1030-2020 was initiated by RemedyRepack Inc. on Aug 5, 2019 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle. The recall status is terminated (terminated Jun 2, 2023). Affected quantity: 480 tablets.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 25, 2020
- Initiation Date
- Aug 5, 2019
- Termination Date
- Jun 2, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 480 tablets
Product description
Lisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 (Repackaged NDC for blister cards).
Reason for recall
Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.
Distribution pattern
PA
Code information
Lot #: J0322819-091418, Exp: 09/30/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1030-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026